Benzinga | May 6, 2021 04:19PM EDT

Collegium Pharmaceutical Q1 EPS $0.41 Beats $0.30 Estimate, Sales $87.72M Beat $81.87M Estimate

Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.30 by 36.67 percent. This is a 4000 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $87.72 million which beat the analyst consensus estimate of $81.87 million by 7.15 percent. This is a 14.65 percent increase over sales of $76.51 million the same period last year.